APA (7th ed.) Citation

Xu, Q., Huang, K., Tong, L., Yan, D., Zhao, Y., Yang, H., . . . Chen, Q. (2025). Intrathecal pemetrexed efficacy and cerebrospinal fluid tumor marker response in refractory leptomeningeal metastasis of non-small-cell lung cancer: A single-arm phase II trial. BMC Medicine, 23(1), 1. https://doi.org/10.1186/s12916-025-04134-7

Chicago Style (17th ed.) Citation

Xu, Qingsheng, et al. "Intrathecal Pemetrexed Efficacy and Cerebrospinal Fluid Tumor Marker Response in Refractory Leptomeningeal Metastasis of Non-small-cell Lung Cancer: A Single-arm Phase II Trial." BMC Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12916-025-04134-7.

MLA (9th ed.) Citation

Xu, Qingsheng, et al. "Intrathecal Pemetrexed Efficacy and Cerebrospinal Fluid Tumor Marker Response in Refractory Leptomeningeal Metastasis of Non-small-cell Lung Cancer: A Single-arm Phase II Trial." BMC Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12916-025-04134-7.